The company said the weight-loss drug will be available at the same self-pay price in either the single-dose vial format or ...

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...

Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve ...

FRANKFURT (Reuters) - The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.

Eli Lilly unveiled a new multi-dose version of its blockbuster obesity drug Zepbound, allowing patients to receive a full ...

The active ingredient in Humulin N is NPH insulin. (An active ingredient is what makes a drug work.) Humulin N comes as a suspension (a type of liquid mixture) that you inject under your skin. It’s ...

Marshall M. Baker, MS, FACMPE, president of the Accreditation Association for Ambulatory Health Care, offers advice on the appropriate use of multi-dose vials. AAAHC has been a SIPC steering committee ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.